-- Orthocell (ASX:OCC) said that a surgery at a military base hospital in Ohio within the US Department of Defense/Veterans Affairs hospital network was the first surgical case using its nerve repair product, Remplir, according to a Friday Australian bourse filing.
The company said that this represented an important step in its US commercialization strategy.